Efficacy of Local Direct Median Nerve Block

April 30, 2023 updated by: Kittipong Siriboonpipattana, Thammasat University

Efficacy of Local Direct Median Nerve Block VS Brachial Plexus Block in Endoscopic Carpal Tunnel Release

Carpal tunnel syndrome is the most common compressive neuropathy. Carpal tunnel release is indicated when failed conservative treatment. Although it can be done either with local anesthesia or brachial plexus block, there is no gold standard of anesthetic choice. The study is conducted to compare the efficacy of two methods and we hypothesized that the local direct median nerve block has effectiveness in intraoperative pain control not inferior to brachial plexus block in endoscopic carpal tunnel release.

Study Overview

Detailed Description

The study is randomized-control trial conducted in single center (Orthopaedic department, Faculty of medicine, Thammasat university) The patients with failed conservative treatment of carpal tunnel syndrome confirmed by EMG are enrolled and ramdomized with computerized block-of-4 method.The local direct median nerve block is done by the surgeon and brachial plexus block in done by single anesthesiologist after that the patient will be operated with 1-portal endoscopic carpal tunnel release (Agee technque) by single surgeon. Immediate postoperative the blinded observer will ask the patient about interaoperative pain in visual analog scale then the pateint is asked to record the 2-hr, 4-hr ,6-hr and 12-hr postoperative pain in case record form.The patient will return the case record form at 2-week and also stitched off the wound then next follow up will be 4, 12, 24 weeks to assess functional outcome (Thai version Bonton questionaire)

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Pathumthani
      • Khlong Luang, Pathumthani, Thailand, 12120
        • Thammasat University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Patient with carpal tunnel syndrome, confirmed by EMG
  2. Failed conservative treatment 3 months
  3. Age ≥18 years old

Exclusion Criteria:

  1. Allergic history of xylocaine
  2. Any other condition that can cause carpal tunnel syndrome or peripheral neuropathy e.g. DM, hypothyroidism, pregnancy, tumor
  3. Any patient that has been coverted to open carpal tunnel release

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Local direct median nerve block
The local anesthetic technique is proposed by Wood SH and Logan AM in 1999 by using the plastic catheter to inject the anesthetic 4 cm proximally to the incision site direct over the median and ulna nerve
local direct median nerve block is performed by surgeon using the 1%xylocaine with adrenaline 12 mL(5 mL subcutaneous at incision site and 7 mL over median nerve) (maximum dose 7 mg/kg) before the endoscopic carpal tunnel release(1-portal Agee technique)
Active Comparator: Brachial plexus block
The brachial plexus block technique is axillary block performed under ultrasound-guided by the well-trained anesthesiologist.
brachial plexus block under ultrasound-guided is performed by experienced single anesthesiologist using the 1%xylocaine with adrenaline 15 mL (maximum dose 7 mg/kg) before the endoscopic carpal tunnel release(1-portal Agee technique)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intraoperative pain measured as visual analog scale (VAS)
Time Frame: Immediate postoperative period

Visual analog scale (VAS) from 0-10 0 means no pain 5 means moderate pain 10 means worst possible pain

Immediate postoperative the blinded observer will ask the patient about interaoperative pain in visual analog scale

Immediate postoperative period

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative pain measured as visual analog scale (VAS)
Time Frame: 2 hours, 4 hours, 6 hours and 12 hours postoperative period

Visual analog scale (VAS) from 0-10 0 means no pain 5 means moderate pain 10 means worst possible pain

The pateint is asked to record the 2 hours, 4 hours, 6 hours and 12 hours postoperative pain in case record form.

2 hours, 4 hours, 6 hours and 12 hours postoperative period
Functional outcome of the hand measured as Thai Version Boston Questionnaire
Time Frame: 2, 4, 12, 24 weeks postoperative period

There are 2 parts of Thai Version Boston Questionnaire

  1. Symptom severity scores (SSS) 11 items (total score 0-55; hign score means worse outcome)
  2. Functional severity scores (FSS) 8 items (total score 0-40; hign score means worse outcome)

The follow up will be 1, 4, 12, 24 weeks to assess functional outcome with Thai Version Boston Questionnaire

2, 4, 12, 24 weeks postoperative period

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Chinnakart Boonyasirikool, MD, Department of Orthopaedics, Faculty of Medicine Thammasat University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2018

Primary Completion (Actual)

February 1, 2021

Study Completion (Actual)

September 1, 2021

Study Registration Dates

First Submitted

June 26, 2020

First Submitted That Met QC Criteria

June 26, 2020

First Posted (Actual)

July 1, 2020

Study Record Updates

Last Update Posted (Actual)

May 3, 2023

Last Update Submitted That Met QC Criteria

April 30, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Carpal Tunnel Syndrome

Clinical Trials on Endoscopic carpal tunnel release under local direct median nerve block

3
Subscribe